Aspen Grove Capital LLC Has $1.94 Million Holdings in VanEck Pharmaceutical ETF $PPH

Posted by Defense World Staff on Jul 24th, 2026

Aspen Grove Capital LLC lowered its stake in VanEck Pharmaceutical ETF (NASDAQ:PPH – Free Report) by 28.7% in the 1st quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 18,676 shares of the company’s stock after selling 7,533 shares during the quarter. Aspen Grove Capital LLC owned 0.20% of VanEck Pharmaceutical ETF worth $1,940,000 at the end of the most recent reporting period.

A number of other institutional investors also recently modified their holdings of PPH. AlphaCore Capital LLC acquired a new position in shares of VanEck Pharmaceutical ETF during the fourth quarter valued at about $31,000. Group One Trading LLC acquired a new position in VanEck Pharmaceutical ETF during the fourth quarter worth $36,000. EFG International AG bought a new position in shares of VanEck Pharmaceutical ETF in the fourth quarter valued at $44,000. IFP Advisors Inc grew its holdings in shares of VanEck Pharmaceutical ETF by 53.7% during the third quarter. IFP Advisors Inc now owns 438 shares of the company’s stock valued at $40,000 after buying an additional 153 shares during the last quarter. Finally, Birchwood Financial Partners Inc. bought a new stake in shares of VanEck Pharmaceutical ETF during the fourth quarter worth about $45,000.

VanEck Pharmaceutical ETF Price Performance

PPH opened at $109.95 on Friday. VanEck Pharmaceutical ETF has a fifty-two week low of $81.74 and a fifty-two week high of $112.58. The firm has a market capitalization of $938.97 million, a PE ratio of 20.21 and a beta of 0.46. The company’s 50-day moving average is $106.34 and its 200 day moving average is $105.61.

VanEck Pharmaceutical ETF Cuts Dividend

The business also recently declared a quarterly dividend, which was paid on Tuesday, July 7th. Investors of record on Wednesday, July 1st were issued a dividend of $0.6248 per share. The ex-dividend date was Wednesday, July 1st. This represents a $2.50 annualized dividend and a yield of 2.3%.

VanEck Pharmaceutical ETF Company Profile

(Free Report)

The VanEck Pharmaceutical ETF (PPH) is an exchange-traded fund that is based on the MVIS US Listed Pharmaceutical 25 index, a market-cap-weighted index of 25 of the largest global pharmaceutical firms. PPH was launched on Feb 1, 2000 and is managed by VanEck.